Re: Letter Agreement regarding ForbearanceLetter Agreement • July 8th, 2024 • Athyrium Opportunities III Co-Invest 1 LP • Pharmaceutical preparations • New York
Reference is hereby made to that certain Indenture, dated as of December 19, 2023 (the “Original Indenture”), between Biora Therapeutics, Inc. (the “Company”) and GLAS Trust Company LLC, as trustee and collateral agent (the “Trustee”), as amended by that certain Supplemental Indenture, dated as of March 12, 2024, between the Company and the Trustee (the Original Indenture, as so supplemented, the “Indenture”), setting forth the terms of the Company’s 11.00% / 13.00% Convertible Senior Secured Notes due 2028 (the “Notes”). Capitalized terms used in this letter agreement (this “Agreement”) have the meanings given them in the Indenture.
